HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Prostaglandin G2

HCID 5280883
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
51982-36-6
Standard SMILES
CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H]2C[C@H]1OO2)OO
InChIKey
SGUKUZOVHSFKPH-YNNPMVKQSA-N
Molecular formula
C20H32O6
Average molar mass
368.5 g/mol
Monoisotopic mass
368.21988874

Overview

Prostaglandin G2 is a prostaglandins G. It has a role as a mouse metabolite and a human metabolite. It is a conjugate acid of a prostaglandin G2(1-).

Names & identifiers

Preferred name
Prostaglandin G2
IUPAC
(Z)-7-[(1R,4S,5R,6R)-6-[(E,3S)-3-hydroperoxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
English name
PROSTAGLANDIN G2
Molecular formula
C20H32O6
Molecular weight
368.46

Names & synonyms

prostaglandin G2PGG251982-36-6PGG(2)AZ87DUD2Y8DTXSID00866229(Z)-7-[(1R,4S,5R,6R)-6-[(E,3S)-3-hydroperoxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid9S,11R-epidioxy-15S-hydroperoxy-5Z,13E-prostadienoic acidCHEBI:27647(5Z)-7-[(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid(5Z)-7-((1R,4S,5R,6R)-6-((1E,3S)-3-hydroperoxyoct-1-en-1-yl)-2,3-dioxabicyclo(2.2.1)heptan-5-yl)hept-5-enoic acid(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-Hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoic acid
Show more names
Prostaglandin?G2?(PGG2)Prostaglandin G2 SolutionSGUKUZOVHSFKPH-KOOCKTTBSA-NProstaglandin G2 DISCONTINUED, UNSTABLEProstaglandin Impurity 8 (Prostaglandin G2)9ALPHA,11ALPHA-EPIDIOXY-15S-HYDROPEROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID(5Z,13E,15S)-9α,11α-Epidioxy-15-hydroperoxyprosta-5,13-dien-1-oic acidProsta-5,13-dien-1-oic acid, 9,11-epidioxy-15-hydroperoxy-, (5Z,9α,11α,13E,15S)-

Properties

Computed structural properties

XLogP
3.8
Topological polar surface area
85.2 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
13
Heavy atoms
26
Formal charge
0
Complexity
475

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
Physical DescriptionSolid
Collision Cross Section · 3 items

190.7 Ų [M-H2O-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

199.3 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

193.6 Ų [M-H]-

Physicochemical properties

Boiling point
517.3 · 517.3±50.0 °C(Predicted)
Density
1.157 · 1.157±0.06 g/cm3(Predicted)
Flash point
-17 °C · -17 °C
storage temp.
70 °C · −70°C
solubility
100 mg/ml; · Ethanol: >100 mg/ml; PBS pH 7.2: >2 mg/ml
form
acetone solution
pka
4.76 · 4.76±0.10(Predicted)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
1
ridadr
UN 1090 3/PG 2
risk_code
11-36-66-67
Signal word
Danger
Symbol(GHS)
GHS02,GHS07
hazard_code
F,Xi
safety_code
9-16-26
Hazard statements
H225-H319-H336
Precautionary statements
P210-P305+P351+P338

Chemistry & industry

Pharmacology

Cellular LocationsExtracellular
Metabolite PathwaysAcetaminophen Action Pathway
Applications · 1 item

UsesProstaglandin G2 is the first intermediary in the COX pathway which is stable enough to be isolated and characterized. It maintains the ability to inhibit indoleamine 2,3-dioxygenase activity and affect immune suppression and tumor induce tolerance.

Upstream & downstream products

Downstream products

5-TRANS PROSTAGLANDIN F2ALPHA

Additional notes

DefinitionChEBI: Prostaglandin G2 is a prostaglandins G. It has a role as a mouse metabolite and a human metabolite. It is a conjugate acid of a prostaglandin G2(1-).

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
(Z)-7-((1R,4S,5R,6R)-6-((E,3S)-3-hydroperoxyoct-1-enyl)-2,3-dioxabicyclo(2.2.1)heptan-5-yl)hept-5-enoic acidRefChem:176618DTXCID501510996(5Z,9S,11R,13E,15S)-15-hydroperoxy-9,11-epidioxyprosta-5,13-dien-1-oateEndoperoxide G2(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acidSGUKUZOVHSFKPH-YNNPMVKQSA-N(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoate

Database identifiers

CAS
51982-36-6
PubChem CID
5280883
DTXSID
DTXSID00866229
ChEBI
CHEBI:27647
UNII
AZ87DUD2Y8
Nikkaji
J10.404C
FDA UNII
87 DUD2Y8 · AZ87DUD2Y8
Symbol(GHS)
2 · GHS02,GHS07
Signal word
Danger
Hazard statements
225 · H225-H319-H336
Precautionary statements
210 · P210-P305+P351+P338
Hazard Codes
F,Xi
Risk Statements
11 · 11-36-66-67
Safety Statements
9 · 9-16-26
RIDADR
1090 · UN 1090 3/PG 2
WGK Germany
1 · 1